163 related articles for article (PubMed ID: 30334342)
21. Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
Ali F; Raufi MA; Washington B; Ghali JK
Cardiovasc Drug Rev; 2007; 25(3):261-79. PubMed ID: 17919259
[TBL] [Abstract][Full Text] [Related]
22. Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failure.
Mondritzki T; Mai TA; Vogel J; Pook E; Wasnaire P; Schmeck C; Hüser J; Dinh W; Truebel H; Kolkhof P
Eur J Heart Fail; 2021 May; 23(5):743-750. PubMed ID: 32946151
[TBL] [Abstract][Full Text] [Related]
23. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
[TBL] [Abstract][Full Text] [Related]
24. N-methyl-D-aspartate receptor antagonist therapy suppresses colon motility and inflammatory activation six days after the onset of experimental colitis in rats.
Érces D; Varga G; Fazekas B; Kovács T; Tőkés T; Tiszlavicz L; Fülöp F; Vécsei L; Boros M; Kaszaki J
Eur J Pharmacol; 2012 Sep; 691(1-3):225-34. PubMed ID: 22796676
[TBL] [Abstract][Full Text] [Related]
25. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model.
Bennink RJ; van Montfrans C; de Jonge WJ; de Bruin K; van Deventer SJ; te Velde AA
Nucl Med Biol; 2004 Jan; 31(1):93-101. PubMed ID: 14741574
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors.
Barbeis C; Balestre MN; Jard S; Tribollet E; Arsenijevic Y; Dreifuss JJ; Bankowski K; Manning M; Chan WY; Schlosser SS
Neuroendocrinology; 1995 Aug; 62(2):135-46. PubMed ID: 8584113
[TBL] [Abstract][Full Text] [Related]
27. Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut.
Kankuri E; Vaali K; Korpela R; Paakkari I; Vapaatalo H; Moilanen E
Inflammation; 2001 Oct; 25(5):301-10. PubMed ID: 11820457
[TBL] [Abstract][Full Text] [Related]
28. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
Zeynalov E; Jones SM; Seo JW; Snell LD; Elliott JP
PLoS One; 2015; 10(8):e0136121. PubMed ID: 26275173
[TBL] [Abstract][Full Text] [Related]
29. Long-term study of TNBS-induced colitis in rats: focus on mast cells.
Menozzi A; Pozzoli C; Poli E; Lazzaretti M; Grandi D; Coruzzi G
Inflamm Res; 2006 Oct; 55(10):416-22. PubMed ID: 17109068
[TBL] [Abstract][Full Text] [Related]
30. Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells.
Stein J; Ries J; Barrett KE
Am J Physiol; 1998 Jan; 274(1):G203-9. PubMed ID: 9458791
[TBL] [Abstract][Full Text] [Related]
31. Persistent alterations to enteric neural signaling in the guinea pig colon following the resolution of colitis.
Lomax AE; O'Hara JR; Hyland NP; Mawe GM; Sharkey KA
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G482-91. PubMed ID: 17008554
[TBL] [Abstract][Full Text] [Related]
32. Vascular contribution of adrenomedullin to microcirculatory improvement in experimental colitis.
Talero E; Alvarez de Sotomayor M; Sánchez-Fidalgo S; Motilva V
Eur J Pharmacol; 2011 Nov; 670(2-3):601-7. PubMed ID: 21958875
[TBL] [Abstract][Full Text] [Related]
33. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.
Koshimizu TA; Nasa Y; Tanoue A; Oikawa R; Kawahara Y; Kiyono Y; Adachi T; Tanaka T; Kuwaki T; Mori T; Takeo S; Okamura H; Tsujimoto G
Proc Natl Acad Sci U S A; 2006 May; 103(20):7807-12. PubMed ID: 16682631
[TBL] [Abstract][Full Text] [Related]
34. Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis.
Poli E; Lazzaretti M; Grandi D; Pozzoli C; Coruzzi G
Neurochem Res; 2001 Sep; 26(8-9):1085-93. PubMed ID: 11699935
[TBL] [Abstract][Full Text] [Related]
35. V1 receptor in ENS mediates the excitatory effect of vasopressin on circular muscle strips of gastric body in vitro in rats.
Qin J; Liu K; Wang PS; Liu C
Regul Pept; 2009 Oct; 157(1-3):32-6. PubMed ID: 19523991
[TBL] [Abstract][Full Text] [Related]
36. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
[TBL] [Abstract][Full Text] [Related]
37. Protection against 2,4,6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongiolide M.
Busserolles J; Payá M; D'Auria MV; Gomez-Paloma L; Alcaraz MJ
Biochem Pharmacol; 2005 May; 69(10):1433-40. PubMed ID: 15857607
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
Xu J; Zheng C; Huang Y; Liang Y
Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
[TBL] [Abstract][Full Text] [Related]
39. Mechanism and prevention of chronic colonic inflammation with trinitrobenzene sulfonic acid in rats.
Hoshino H; Sugiyama S; Ohara A; Goto H; Tsukamoto Y; Ozawa T
Clin Exp Pharmacol Physiol; 1992 Oct; 19(10):717-22. PubMed ID: 1424301
[TBL] [Abstract][Full Text] [Related]
40. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
Dudhgaonkar SP; Tandan SK; Kumar D; Raviprakash V; Kataria M
Inflammopharmacology; 2007 Oct; 15(5):188-95. PubMed ID: 17943250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
